Wartenberg-Demand; Andrea
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wartenberg-Demand; Andrea.The latest application filed is for "treatment of severe community acquired pneumonia".
- Wartenberg-Demand; Andrea - Schrecksbach DE
- Wartenberg-Demand; Andrea - Linden DE
| Patent | Date |
|---|---|
| Treatment Of Severe Community Acquired Pneumonia App 20210162043 - Langohr; Patrick ; et al. | 2021-06-03 |
| Treatment of severe community acquired pneumonia Grant 10,918,715 - Langohr , et al. February 16, 2 | 2021-02-16 |
| Treatment Of Severe Community Acquired Pneumonia App 20200268881 - Langohr; Patrick ; et al. | 2020-08-27 |
| Uses Of Immunoconjugates Targeting Cd138 App 20190117770 - Schulz; Gregor ; et al. | 2019-04-25 |
| Treatment Of Severe Community Acquired Pneumonia App 20190076523 - Langohr; Patrick ; et al. | 2019-03-14 |
| Uses of immunoconjugates targeting CD138 Grant 10,117,932 - Schulz , et al. November 6, 2 | 2018-11-06 |
| Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 9,605,066 - Osterroth , et al. March 28, 2 | 2017-03-28 |
| Method for treating psoriasis Grant 9,550,831 - Aigner , et al. January 24, 2 | 2017-01-24 |
| Agent for treating disease Grant 9,512,226 - Germer , et al. December 6, 2 | 2016-12-06 |
| Method for treating psoriasis Grant 9,334,325 - Osterroth , et al. May 10, 2 | 2016-05-10 |
| Uses of immunoconjugates targeting CD138 Grant 9,289,509 - Osterroth , et al. March 22, 2 | 2016-03-22 |
| Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20150064179 - OSTERROTH; FRANK ; et al. | 2015-03-05 |
| Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 8,852,871 - Osterroth , et al. October 7, 2 | 2014-10-07 |
| Uses Of Immunoconjugates Targeting Cd138 App 20140010828 - Schulz; Gregor ; et al. | 2014-01-09 |
| Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20120321618 - Osterroth; Frank ; et al. | 2012-12-20 |
| Composition For Treating Disease App 20110229465 - Osterroth; Frank ; et al. | 2011-09-22 |
| Uses Of Immunoconjugates Targeting Cd138 App 20110123554 - Osterroth; Frank ; et al. | 2011-05-26 |
| Agent For Treating Disease App 20110059084 - OSTERROTH; FRANK ; et al. | 2011-03-10 |
| Agent For Treating Disease App 20110059083 - AIGNER; SILKE ; et al. | 2011-03-10 |
| Agent For Treating Disease App 20110059082 - Germer; Matthias ; et al. | 2011-03-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 